Skip to main content
OpenTrials

Clinical trial condition

Neovascular Age-related Macular Degeneration

Explore clinical trials studying Neovascular Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.

148 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Neovascular Age-related Macular Degeneration trial results

Completed

CLN-0046: Treatment of AMD Subjects With OTX-TKI

NCT03630315

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Ocular Therapeutix, Inc. Sydney, Site 1, Australia
  • Ocular Therapeutiux, Inc. Sydney, Site 2, Australia
  • Ocular Therapeutiux, Inc. Sydney, Site 3, Australia
  • Ocular Therapeutix, Inc. Adelaide, Australia
View Trial Details
Completed

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

NCT04662944

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Novartis Investigative Site Hamilton, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Ludwigsburg, Baden-Wurttemberg, Germany
View all 17 locations
View Trial Details
Completed

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration

NCT04864834

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Sandoz Investigational Site Phoenix, Arizona, United States
  • Sandoz Investigational Site Arcadia, California, United States
  • Sandoz Investigational Site Campbell, California, United States
  • Sandoz Investigational Site Encino, California, United States
View all 102 locations
View Trial Details
Completed

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

NCT05131646

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • Northern California Retina Vitreous Associates Medical Group, LLC Mountain View, California, United States
  • Retina Consultants Medical Group, Inc Sacramento, California, United States
  • Southeast Retina Center Augusta, Georgia, United States
View Trial Details
Completed

A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT04450329

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • SB Investigative Site Colorado Springs, Colorado, United States
  • SB Investigative Site Chevy Chase, Maryland, United States
  • SB Investigative Site Abilene, Texas, United States
  • SB Investigative Site Osijek, Croatia
View all 38 locations
View Trial Details
Completed

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

NCT04989699

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Ocular Therapeutix Bakersfield, California, United States
  • Ocular Therapeutix Oxnard, California, United States
  • Ocular Therapeutix Altamonte Springs, Florida, United States
  • Ocular Therapeutix St. Petersburg, Florida, United States
View Trial Details

Related conditions